Form D · Biotechnology
Koyo Sciences Inc.
Brookline, MA · CIK 0002073451
Offering snapshot reported Jun 18, 2025 · SEC filing
- Reported sold
- $1.28M Offering amount: $20.4M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $111K Reported outside-investor minimum
- First sale
- Jun 4, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 18, 2025 | Initial | $1,278,225 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-549223
Source: Form D, filed Jun 18, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Dove | Director, Executive |
| Jonathan Daniel Reis | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
146 Winthrop Road
Brookline, MA, 02445
Brookline, MA, 02445